US Corporate Board Director Changes SEC Filings — February 12, 2026

13-02-2026

ALLIANCE ENTERTAINMENT HOLDING CORP filed an 8-K on February 13, 2026 (AccNo: 0001493152-26-006492), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), alongside results of operations and financial condition (Item 2.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). Specific details on the officer change, including name, position, appointment or resignation status, reasons, and timing, are NOT_DISCLOSED. No quantitative financial metrics, period-over-period comparisons, or other numerical data are mentioned.

13-02-2026

Bloomin' Brands, Inc. filed an 8-K on 2026-02-13 disclosing an officer change under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the officer's name, position, reason for change, or timing are disclosed.

13-02-2026

GENCO SHIPPING & TRADING LTD filed an 8-K on 2026-02-13 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the affected position, names, reasons, or timing were disclosed.

13-02-2026

Sonic Automotive Inc filed an 8-K on February 13, 2026 (AccNo: 0001628280-26-007898) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any quantitative impacts are disclosed. This is a standard governance filing with no financial metrics, performance data, or scheduled events mentioned.

13-02-2026

LCI Industries filed an 8-K on February 13, 2026 (AccNo: 0000763744-26-000004, size 705 KB), disclosing an officer change under Item 5.02 covering departure of directors or certain officers, election or appointment of directors/officers, and compensatory arrangements of certain officers. The filing also includes Regulation FD disclosure under Item 7.01 and financial statements and exhibits under Item 9.01. No specific details on affected positions, individuals, reasons for change, or financial metrics are disclosed.

• ·Event date: February 13, 2026
• ·Source: us_sec
• ·Sector: not specified

13-02-2026

LAS VEGAS SANDS CORP filed an 8-K on 2026-02-13 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure (Item 7.01), Other Events (Item 8.01), and Financial Statements and Exhibits (Item 9.01). No specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are provided. Sector is not specified.

13-02-2026

The company filed an 8-K on February 13, 2026 (AccNo: 0001331754-26-000028), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). No specific details on the affected officer's name, position (e.g., CEO, CFO), nature of change (appointment or resignation), reasons, or effective date beyond the filing date are provided. No quantitative data, financial metrics, or additional context such as board impacts or succession planning is disclosed.

13-02-2026

SOUTH DAKOTA SOYBEAN PROCESSORS LLC filed an 8-K on 2026-02-13 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any financial metrics are provided in the available information. No quantitative data, performance comparisons, or other outcomes are mentioned.

13-02-2026

Graco Inc filed a Form 8-K on February 13, 2026 (AccNo: 0000042888-26-000036, size 141 KB), disclosing information under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as affected positions (e.g., CEO, CFO), individuals involved, reasons for the change, effective dates, or any quantitative terms are explicitly stated. This represents a standard officer change event with sector not specified and no associated financial metrics or performance comparisons provided.

• ·AccNo: 0000042888-26-000036
• ·Event Type: Officer Change
• ·Source: us_sec

13-02-2026

Mag Magna Corp filed an 8-K on February 13, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). No specific details on the key position affected, individual names, appointment or resignation status, reasons, or timing are disclosed. Sector information is not specified.

13-02-2026

Data Storage Corp filed an 8-K on February 13, 2026, disclosing an event under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals, reasons for changes, or any quantitative metrics are disclosed.

13-02-2026

POOL CORP filed an 8-K on February 13, 2026 (AccNo: 0001193125-26-051351), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details including affected positions, names, reasons for the change, internal/external status, and timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or other material impacts are mentioned.

13-02-2026

FOX FACTORY HOLDING CORP filed an 8-K on February 13, 2026 (AccNo: 0001424929-26-000004), disclosing information under Item 5.02 regarding Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details on affected positions, individuals involved, reasons for change, or any compensatory arrangements are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

13-02-2026

BiomX Inc. filed an 8-K on 2026-02-13 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons, timing, or any quantitative metrics are disclosed. No positive or negative performance metrics are mentioned.

13-02-2026

LendingTree, Inc. filed an 8-K on February 13, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or timing are disclosed. No financial metrics, quantitative data, or other outcomes such as board decisions are mentioned.

13-02-2026

Texas Roadhouse, Inc. filed a Form 8-K on 2026-02-13 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or impacts are disclosed. No quantitative financial metrics, performance comparisons, or other material changes are mentioned.

13-02-2026

Offerpad Solutions Inc. filed an 8-K on February 13, 2026 (AccNo: 0001193125-26-051334), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the key position affected, individuals involved, reasons for the change, or any quantitative impacts are disclosed.

13-02-2026

e.l.f. Beauty, Inc. filed an 8-K on 2026-02-13 under Item 5.02 disclosing a matter related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the affected position, individuals involved, reason for change, or any financial impacts are provided. No quantitative metrics, performance data, or scheduled events mentioned.

13-02-2026

Newell Brands Inc. filed a Form 8-K on 2026-02-13 disclosing matters under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative metrics are disclosed.

13-02-2026

SpyGlass Pharma, Inc. filed an 8-K on February 13, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, appointment or resignation status, reasons for change, or any financial metrics are provided in the available information. No positive or negative impacts, quantitative data, or further context such as board composition changes are disclosed.

13-02-2026

Kestrel Group Ltd filed an 8-K on February 13, 2026 (AccNo: 0001628280-26-008071), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on the affected position, individual names, appointment/resignation status, reasons, or impacts are disclosed.

13-02-2026

PLUS Therapeutics, Inc. filed an 8-K on February 13, 2026 (AccNo: 0001193125-26-051379) under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on individuals, positions, reasons for change, or terms are disclosed. No quantitative metrics, financial impacts, or other changes are mentioned.

13-02-2026

Centessa Pharmaceuticals plc filed an 8-K on 2026-02-13 (AccNo: 0001193125-26-051424, Size: 189 KB) under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on key position affected (e.g., CEO, CFO), appointment or resignation status, reasons, timing, or any financial metrics are disclosed. No positive or negative governance implications can be assessed due to lack of details.

• ·AccNo: 0001193125-26-051424
• ·Filing size: 189 KB
• ·Sector: not specified

13-02-2026

Live Oak Bancshares, Inc. filed an 8-K on February 13, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits are included. No specific details such as officer names, positions affected, appointment or resignation status, reasons, or quantitative data are disclosed.

13-02-2026

Apple Hospitality REIT, Inc. filed a Form 8-K on 2026-02-13 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for the change, or timing are provided in the filing summary. No quantitative data, performance metrics, or further governance implications are disclosed.

13-02-2026

SAGA COMMUNICATIONS INC filed an 8-K on February 13, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the officer's name, title, reason for change, timing, or any quantitative metrics are disclosed.

13-02-2026

Werewolf Therapeutics, Inc. filed an 8-K on February 13, 2026, disclosing costs associated with exit or disposal activities under Item 2.05, officer or director changes including departures, elections, appointments, or compensatory arrangements under Item 5.02, and Regulation FD disclosure under Item 7.01. No specific details on personnel changes, reasons, costs, or financial impacts are disclosed. This combination signals potential restructuring but lacks quantification for assessment.

13-02-2026

QuidelOrtho Corp filed an 8-K on February 13, 2026 (AccNo: 0001193125-26-051461), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). No specific details on the affected officer, position, reason for change, or timing are disclosed. Sector is not specified.

• ·Filing size: 130 KB

13-02-2026

NORTHROP GRUMMAN CORP /DE/ filed an 8-K on February 13, 2026 (AccNo: 0001628280-26-008140), disclosing an officer change event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on the affected officer, position, action (appointment or resignation), reason, effective date, or any quantitative data are disclosed.

• ·Event Type: Officer Change
• ·Source: us_sec
• ·Sector: not specified
• ·Filing Size: 190 KB

13-02-2026

Knight-Swift Transportation Holdings Inc. filed an 8-K on February 13, 2026 (AccNo: 0001492691-26-000012), disclosing information under Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or financial terms are disclosed in the provided filing summary. No quantitative metrics, performance comparisons, or scheduled events mentioned.

13-02-2026

Lithia Motors Inc filed an 8-K on February 13, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) with Item 9.01 for Financial Statements and Exhibits. No specific details on the key position affected, appointment or resignation, reasons, or timing are disclosed. No quantitative financial metrics, performance comparisons, or other changes are mentioned.

13-02-2026

Peraso Inc. filed an 8-K on February 13, 2026 (AccNo: 0001213900-26-016466), disclosing an officer change under Item 5.02 covering departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific names, positions affected, reasons for change, or quantitative details are disclosed.

• ·File size: 189 KB

13-02-2026

International Tower Hill Mines Ltd filed an 8-K on February 13, 2026 (AccNo: 0001104659-26-015257), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and exhibits under Item 9.01. No specific details on the key position affected, individuals involved, appointment or resignation status, reasons, or timing are disclosed. No quantitative financial metrics, performance comparisons, or other material data points are provided in the filing summary.

13-02-2026

Goldman Sachs Group Inc filed an 8-K on February 13, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for changes, or impacts are disclosed. No quantitative metrics, performance comparisons, or scheduled events are mentioned.

13-02-2026

AMERICAN STATES WATER CO filed a Form 8-K on February 13, 2026 (AccNo: 0001628280-26-008178), disclosing an officer change under Item 5.02, which pertains to departures of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, timing, or any named individuals are provided in the filing summary. No quantitative data, financial metrics, or further governance implications are disclosed.

13-02-2026

Longeveron Inc. filed an 8-K on 2026-02-13 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates Financial Statements and Exhibits were included. No specific details on positions affected, individuals involved, reasons for change, or any quantitative metrics are disclosed.

13-02-2026

Kontoor Brands, Inc. filed an 8-K on February 13, 2026 (AccNo: 0001760965-26-000006), disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), other events under Item 8.01, and financial statements/exhibits under Item 9.01. Specific details including the key position affected, individual names, appointment/resignation status, reasons, or any quantitative impacts are NOT_DISCLOSED.

13-02-2026

CoStar Group, Inc. filed an 8-K on February 13, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals, reasons, or terms are disclosed.

13-02-2026

NexMetals Mining Corp. filed an 8-K on 2026-02-13 disclosing an officer or director change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Other Events in Item 8.01 and Financial Statements and Exhibits in Item 9.01. Specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, or individuals involved are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.

13-02-2026

BayFirst Financial Corp. filed an 8-K on 2026-02-13 disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the individuals involved, reasons for change, timing, or impacts are disclosed.

13-02-2026

Timken Co filed an 8-K on February 13, 2026 (AccNo: 0000098362-26-000014) disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Specific details including the key position affected (e.g., CEO, CFO), whether it is an appointment or resignation, reasons for the change, internal/external status, and any board composition impacts are NOT_DISCLOSED. No quantitative data, financial metrics, scheduled events, or governance implications are provided in the summary.

13-02-2026

Zenas BioPharma, Inc. filed an 8-K on 2026-02-13 disclosing officer changes under Item 5.02, including potential departures of directors or certain officers, elections of directors, appointments of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific names, positions, reasons for changes, financial metrics, or quantitative details are disclosed.

13-02-2026

UFP Technologies Inc filed an 8-K on February 13, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 refers to financial statements and exhibits. No specific details on affected positions, individuals, reasons for changes, or financial metrics are disclosed.

13-02-2026

IDEXX Laboratories Inc./DE filed an 8-K on February 13, 2026 (AccNo: 0000874716-26-000007, Size: 276 KB) under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, timing, or quantitative impacts are disclosed. This is a routine governance disclosure with no financial metrics or performance data provided.

13-02-2026

Actinium Pharmaceuticals, Inc. filed an 8-K on February 13, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, names, reasons for change, or quantitative data are disclosed. Sector information is not specified.

13-02-2026

Orchestra BioMed Holdings, Inc. filed an 8-K on February 13, 2026 (AccNo: 0001104659-26-015315), disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific names, titles, reasons for changes, timing details, compensation amounts, or other quantitative metrics are disclosed. Sector information is not specified.

13-02-2026

Delta Air Lines, Inc. filed an 8-K on February 13, 2026 (AccNo: 0001683168-26-001033), disclosing information under Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, or impacts were provided. Sector not specified.

13-02-2026

Sensei Biotherapeutics, Inc. filed an 8-K on February 13, 2026 (AccNo: 0001193125-26-051815), disclosing information under Item 5.02 regarding departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, or any quantitative metrics such as compensation amounts are disclosed. No positive or negative performance metrics, comparisons, or financial impacts are mentioned.